These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24313827)

  • 41. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liposomes and nanoparticles in the treatment of intracellular bacterial infections.
    Couvreur P; Fattal E; Andremont A
    Pharm Res; 1991 Sep; 8(9):1079-86. PubMed ID: 1788152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanoparticle-mediated delivery of the antimicrobial peptide plectasin against Staphylococcus aureus in infected epithelial cells.
    Water JJ; Smart S; Franzyk H; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2015 May; 92():65-73. PubMed ID: 25701808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications.
    Pinto-Alphandary H; Andremont A; Couvreur P
    Int J Antimicrob Agents; 2000 Jan; 13(3):155-68. PubMed ID: 10724019
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liposome encapsulation: a method for enhancing the effectiveness of local antibiotics.
    Price CI; Horton JW; Baxter CR
    Surgery; 1994 Apr; 115(4):480-7. PubMed ID: 8165539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Glycosylation-mediated targeting of carriers.
    Kawakami S; Hashida M
    J Control Release; 2014 Sep; 190():542-55. PubMed ID: 24915504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly stable, protein capped gold nanoparticles as effective drug delivery vehicles for amino-glycosidic antibiotics.
    Rastogi L; Kora AJ; J A
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1571-7. PubMed ID: 24364962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biodegradable gentamicin delivery systems for parenteral use for the treatment of intracellular bacterial infections.
    Gamazo C; Prior S; Concepción Lecároz M; Vitas AI; Campanero MA; Pérez G; Gonzalez D; Blanco-Prieto MJ
    Expert Opin Drug Deliv; 2007 Nov; 4(6):677-88. PubMed ID: 17970669
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liposomes as delivery systems in the prevention and treatment of infectious diseases.
    Bergers JJ; ten Hagen TL; van Etten EW; Bakker-Woudenberg IA
    Pharm World Sci; 1995 Jan; 17(1):1-11. PubMed ID: 7719272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functionalization of biomolecules on nanoparticles: specialized for antibacterial applications.
    Veerapandian M; Yun K
    Appl Microbiol Biotechnol; 2011 Jun; 90(5):1655-67. PubMed ID: 21523475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silk fibroin nanoparticle as a novel drug delivery system.
    Mottaghitalab F; Farokhi M; Shokrgozar MA; Atyabi F; Hosseinkhani H
    J Control Release; 2015 May; 206():161-76. PubMed ID: 25797561
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome-encapsulated aminoglycosides in pre-clinical and clinical studies.
    Schiffelers R; Storm G; Bakker-Woudenberg I
    J Antimicrob Chemother; 2001 Sep; 48(3):333-44. PubMed ID: 11532996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa.
    Hadinoto K; Cheow WS
    Colloids Surf B Biointerfaces; 2014 Apr; 116():772-85. PubMed ID: 24656614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.
    Malam Y; Loizidou M; Seifalian AM
    Trends Pharmacol Sci; 2009 Nov; 30(11):592-9. PubMed ID: 19837467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.
    Gupta U; Jain NK
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery.
    Fan Y; Marioli M; Zhang K
    J Pharm Biomed Anal; 2021 Jan; 192():113642. PubMed ID: 33011580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.